NCT01321034View on ClinicalTrials.gov

Effect of Niacin in the Lipoprotein (a) Concentration

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

December 31, 2012

Conditions
Hypercholesterolemia
Interventions
DRUG

Niacin/Laropiprant

1g/20 mg day of Niacin/Laropiprant for 4-weeks followed by 8 additional weeks of 2 g/40 mg day.

Trial Locations (3)

50009

Hospital Universitario Miguel Servet, Zaragoza

Unknown

Hospital San Jorge, Huesca

Hospital Royo Villanova, Zaragoza

All Listed Sponsors
collaborator

Hospital Miguel Servet

OTHER

lead

Instituto Aragones de Ciencias de la Salud

OTHER_GOV

NCT01321034 - Effect of Niacin in the Lipoprotein (a) Concentration | Biotech Hunter | Biotech Hunter